Pregnancy: There are no adequate data from the use of levofloxacin in pregnant women. Animal studies do not indicate direct or indirect harmful effects with respect to reproductive toxicity (see Pharmacology: Toxicology: Preclinical safety data under Actions). The potential risk for humans is unknown. Levofloxacin 5 mg/ml eye drops should be used during pregnancy only if the potential benefit justifies the potential risk to the foetus.
Breastfeeding: Levofloxacin is excreted in human milk. However, at therapeutic doses of Levofloxacin no effects on the suckling child are anticipated. Levofloxacin 5 mg/ml eye drops should be used during lactation only if the potential benefit justifies any potential risk to the nursing child.
Fertility: Levofloxacin caused no impairment of fertility in rats at exposures considerably in excess of the maximum human exposure after ocular administration (see Pharmacology: Toxicology: Preclinical safety data under Actions).
Sign Out